The North America continuous glucose monitoring (CGM) market is experiencing impressive growth, driven by the rising prevalence of diabetes and advancements in real-time glucose monitoring technologies. In 2024, the market stood at USD 6.56 billion and is projected to grow at a CAGR of 14.50%, reaching approximately USD 25.41 billion by 2034. To explore detailed market forecasts, drivers, and emerging opportunities, refer to the Expert Market Research report on the North America CGM Market for comprehensive insights into this rapidly evolving segment.
North America Continuous Glucose Monitoring Market Size
Continuous glucose monitoring systems have transformed diabetes care in North America. These systems enable individuals to measure their blood glucose levels in real-time, significantly improving glycemic control and reducing the risk of complications. The growing population of diabetes patients—particularly those with Type 1 and Type 2 diabetes, has driven the demand for CGM devices across the region.
Advancements in sensor miniaturization, improved accuracy, and mobile integration have also contributed to widespread adoption. The United States accounts for the majority of the market share, supported by a robust healthcare infrastructure and strong presence of leading manufacturers.
North America Continuous Glucose Monitoring Market Share
In terms of market share, sensors dominate the CGM component segment. As the core technology behind glucose tracking, sensors are indispensable in every CGM device, needing frequent replacements—thus contributing significantly to recurring revenue streams.
Abbott and Dexcom, Inc. hold leading positions in the regional market due to their early entry and strong product portfolios. Medtronic also plays a critical role, especially in integrated CGM-insulin pump systems. Among applications, Type 1 diabetes accounts for the largest market share due to the clinical necessity of continuous glucose monitoring in insulin-dependent patients.
Geographically, the United States dominates, with Canada following. The former benefits from high healthcare expenditure and increased awareness, while Canada's market growth is supported by favorable reimbursement policies and national diabetes prevention programs.
North America Continuous Glucose Monitoring Market Growth & Trends
Key trends and growth factors shaping the North America CGM market include:
-
Rising Diabetes Incidence: With an estimated 38 million Americans living with diabetes (according to the CDC), the need for accurate and continuous glucose monitoring has never been greater.
-
Consumer Preference for Wearable Health Tech: Tech-savvy patients are increasingly turning to smart sensors that integrate with mobile apps and smartwatches, enabling better self-management of their condition.
-
Shift Toward Home Healthcare: Post-COVID, there has been an acceleration in remote patient monitoring and home-based glucose tracking—boosting CGM adoption in the home healthcare segment.
-
Product Innovation: New product launches, including implantable sensors and needle-free devices, are helping address patient comfort and convenience, thereby increasing market penetration.
For instance, Senseonics, Inc. recently introduced an implantable CGM system with a 180-day sensor life—one of the longest in the market.
North America Continuous Glucose Monitoring Market Case Studies & News
The CGM market has seen a flurry of activity in recent years:
-
Dexcom’s G7 Launch: Dexcom launched its G7 system in North America with improved accuracy and a smaller, all-in-one wearable design. The G7 has received strong FDA backing and is seeing rapid adoption among both adult and pediatric patients.
-
Abbott’s Libre 3 Approval: Abbott received FDA clearance for its FreeStyle Libre 3 system, which boasts continuous, real-time glucose readings every minute and a 14-day wear time.
-
Partnerships and Expansions: In 2023, Roche Diabetes Care entered into partnerships with digital health platforms to integrate CGM data with AI-powered analytics for improved diabetes management insights.
These innovations are not only enhancing the quality of care but also helping manufacturers strengthen their market presence through differentiated offerings.
North America Continuous Glucose Monitoring Market Analysis
The competitive landscape is moderately consolidated, with a few global players dominating. Market dynamics are influenced by:
-
Pricing Strategies: Competitive pricing and insurance coverage play a key role in adoption.
-
Regulatory Approvals: FDA approvals and Health Canada certifications are essential to ensure product safety and efficacy.
-
Technological Differentiation: Companies that provide longer wear time, improved connectivity, and minimal invasiveness are gaining competitive advantage.
The region’s market is also supported by favorable initiatives, such as the Affordable Care Act (ACA) in the U.S., and expanded coverage of CGM systems by Medicare and private insurers, which is helping drive usage among older adults.
North America Continuous Glucose Monitoring Market Segmentation
By Component:
-
Sensors: Most critical and frequently replaced part of CGM systems.
-
Transmitters: Relay data from sensors to receivers or mobile apps.
-
Receivers: Standalone devices or mobile interfaces that display glucose readings.
By Application:
-
Type 1 Diabetes: Largest market share due to high dependency on continuous monitoring.
-
Type 2 Diabetes: Growing steadily with lifestyle changes and increased monitoring awareness.
-
Others: Includes gestational diabetes and pre-diabetic conditions.
By Age Group:
-
Adult Population: Majority of CGM users, especially for Type 2 diabetes.
-
Child Population: Usage expanding due to pediatric FDA approvals and parental monitoring tools.
By End User:
-
Hospitals & Clinics: Essential for acute glucose management and initial diagnosis.
-
Home Healthcare: Fastest-growing segment due to user-friendly, wearable technologies.
-
Others: Includes sports performance and wellness applications.
By Country:
-
United States of America: Accounts for the bulk of the regional market.
-
Canada: Emerging growth opportunities with expanding public health initiatives.
North America Continuous Glucose Monitoring Market Key Players
Major companies shaping the North America continuous glucose monitoring market include:
-
Abbott
-
Dexcom, Inc.
-
Medtronic PLC
-
Senseonics, Inc.
-
Byram Healthcare Centers, Inc.
-
Hoffmann-La Roche Limited
These firms are continuously investing in R&D, collaborating with tech platforms, and securing regulatory approvals to strengthen their market positions and meet the evolving needs of diabetes patients.
Explore More Reports
Electronic Health Records (EHR) Market
Implantable Medical Devices Market
Allergic Rhinitis Epidemiology Forecast
About Us:
Expert Market Research is a leading market research firm delivering data-driven insights to the pharmaceutical, biotechnology, and medical device industries. Our comprehensive research solutions include market research reports, providing in-depth analysis of industry trends and competitive landscapes; drug pipeline reports, tracking drug development progress, clinical trials, and regulatory approvals; epidemiology reports, offering detailed disease prevalence and patient population studies; and patent reports, assessing intellectual property landscapes and innovation trends, among others.
Leveraging proprietary data, advanced analytics, and expert methodologies, we help businesses navigate complex markets, optimize strategies, and drive innovation. We empower clients with actionable intelligence, enabling them to make informed decisions and stay ahead in the rapidly evolving healthcare sector.
Media Contact:
Company Name: Claight Corporation
Contact Person: Roshan Kumar, Digital Marketing
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com